FRIDAY, June 6, 2025 (HealthDay News) — Attorneys general from four states are asking the U.S. Food and Drug Administration ...

Four attorneys general filed a petition with the FDA to lift restrictions on the abortion medication mifepristone.

The petition, filed by Massachusetts, New York, California, and New Jersey, aims to compel the FDA to recognize that mifepristone is safe and effective. More reproductive health news includes GLP-1 ...

The petition urges the agency to do away with an “unnecessary” and “burdensome” regulatory framework that significantly ...

Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, ...

AG Campbell leads a push to lift FDA restrictions on the abortion pill mifepristone, citing safety and state-level regulation ...

California Attorney General Rob Bonta and three other Attorneys General filed a petition with the Food and Drug Administration (FDA), asking them to reduce the Mifepristone risk evaluation and mitigat ...

Four blue states are asking the U.S. Food and Drug Administration to remove restrictions on a key abortion medication and ...

The American Civil Liberties Union of Kentucky recently dropped a lawsuit it filed last year challenging Kentucky’s ...

The attorneys general of New York, California, Massachusetts and New Jersey asked the FDA to lift some requirements on ...

As the Food and Drug Administration undertakes a full agency review of the safety of the chemical abortion drug mifepristone, ...

The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill’s safety.